Epalex

Epalex Corporation is a specialty pharmaceutical company focused on developing innovative therapies for patients with neurological disorders, particularly migraine and epilepsy. Founded in 2009 and based in Mountain View, California, Epalex is advancing treatments like EP-102, an oral medication for acute migraine, and EP-103 for acute repetitive seizures. Additionally, the company is pioneering a novel inhaled treatment that empowers patients to manage their epilepsy. This treatment utilizes a pocket nebulizer to deliver an antiseizure medication at the onset of a seizure warning sign, enabling rapid intervention and allowing patients to quickly return to their daily activities. Epalex's approach aims to provide sustainable solutions for individuals experiencing generalized epilepsies and migraine attacks that are resistant to existing treatments.